Plasmid-free clone of E. coli strain DSM 6601

Details Plasmid-free clone of E. coli strain DSM 6601 Plasmid-free clone of E. coli strain DSM 6601

2011-08-09

2011-08-09

Joike, Michele (Department: 1636)

Chemistry: molecular biology and microbiology

Micro-organism, per se ; compositions thereof; proces of...

Bacteria or actinomycetales; media therefor

C435S252300

Reexamination Certificate

active

07993902

ABSTRACT:
The invention relates to a plasmid-free clone ofEscherichia colistrain DSM 6601, to a method for preparing the same and to the use thereof as a cloning vehicle.

REFERENCES:
patent: 4686184 (1987-08-01), Puhler et al.
patent: 6391631 (2002-05-01), Hacker et al.
patent: WO 98/44134 (1998-10-01), None
patent: WO 99/26642 (1999-06-01), None
patent: WO 00/78925 (2000-12-01), None
Kruis et al. Maintaining remission of ulcerative colitis with the probioticEscherichia coliNissle 1917 is as effective with standard mesalazine. Gut, 53(11): 1617-1623, 2004.
Trevors et al. Plasmid curing in bacteria. FEMS Microbiol. Reviews 32: 149-157, 1986.
Uraji et al. A novel plasmid curing method using incompatibility of plant pathogenic Ti plasmids inAgrobacterium tumefaciens. Genes Genet. Syst. 77: 1-9, 2002.
Alexeyev et al. Improved antibiotic-resistance gene cassettes and omega elements forEscherichia colivector construction and in vitro deletion/insertion mutagenesis. Gene 160: 63-67, 1995.
Gasson et al. Plasmid complements ofStreptococcus lactisNCDO 712 and other lactic streptococci after protoplast-induced curing. J Bacteriol. Apr. 1983; 154(1): 1-9.
International Search Report in corresponding PCT application PCT/EP2004/006886, mailed Apr. 10, 2004, 2 pages.
Duval-Iflah Y et al., “Implantation of a strain ofEscherichia coliin the degestive tract of human newborns: barrier effect against antibioresistantE. coli”, Annales De Microbiologic, May-Jun. 1982, vol .133, No. 3, May 1982, pp. 393-408.
Kruls W. et al., “Einsatz von Probiotika in der Humanmedizin”, Die Medizinische Welt, 1996, pp. 53-57.
Internet search: “Inhibitory effect of probioticEscherichia colistrain Nissle 1917” www.ingenta.com, 1 page.
Instruction pamphlet for Mutaflor (effective substance:Escherichia colistrain Nissle 1917), by Ardeypharm GmbH, 4 pages. (in German).
English translation of Instruction pamphlet for Mutaflor (effective substance:Escherichia colistrain Nissle 1917), by Ardeypharm GmbH, 3 pages.
Blum et al. “Properties ofEscherichia coliStrains of Serotype O6”, Plasmid, New York, NY, vol. 23, No. 4, Jul. 1, 1995, pp. 234-236.
Cukrowska et al., “Specific Proliferative and Antibody Responses of Premature Infants to Intestinal Colonization with Nonpathogenic ProbioticE. coliStrain Nissle 1917”, Scand. J. Immunol., vol. 55, No. 2, Feb. 2002, pp. 204-209.
Figueiredo et al. “Influence of oral inoculation with plasmid-free humanEscherichia colionthe frequency of diarrhea during the first year of life in human newborns”, J. of Pediatric Gastroenterology and Nutrition, Jul. 2001, vol. 33, No. 3, May 1982, pp. 393-408.
Tolker-Nielsen et al. “A statistical analysis of the formation of plasmid-free cells in populations ofEscherichia coli,” J. Bacteriology, Jul. 1994, vol. 176, No. 14, pp. 4306-4310.
Hynes et al., “Direct selection and deletion ofRhizobiumplasmids using transposons carrying theBacillus subtilissacB gene”, Gene, vol. 78, 1989, pp. 111-120.
Blum-Oehler et al. “Development of strain-specific PCR reactions for the detection of the probioticEscherichia colistrain Nissle 1917 in fecal samples”, Research in Microbiology, vol. 154 (2003) pp. 59-66.
Boudeau et al., “Inhibitory effect of probioticEschericia colistrain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasiveE. colistrains isolated from patients with Crohn's disease”, Aliment Pharmacol Ther, 2003, vol. 18, pp. 45-56.
Patzer et al., “The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN”, Microbiology (2003), vol. 149, pp. 2557-2570.
Fric et al., “The effect of non-pathogenicEscherichia coliin symptomatic uncomplicated diverticular disease of the colon”, European Journal of Gastroenterology & Hepatology, 2003, vol. 15, pp. 313-315.
Waidmann et al., “Bacteroides vulgatus protects againstEscherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice”, Gastroenterology, 2003, vol. 125, pp. 162-177.
Tromm et al., “The probioticE. coliStrain Nissle 1917 for the Treatment of Collagenous Colitis: First Results of an Open-Label Trial”, Gastroenterology 2004, vol. 42, pp. 365-369.
Alterhoefer et al., “The pribioticEscherichia colistrain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens”, FEMS Immunology and Medical Mimcrobiology, 40 (2004), pp. 223-229.
Schultz et al., “Preventive effects ofEscherichia coilStrain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis”, Clinical and Diagnostic Laboratory Immunology, Mar. 2004, vol. 11, No. 2, pp. 372-378.
Otte et al., “Functional modulation of enterocytes by gram-positive and gram-negative microorganisms”, Am J. Physiol. Gastrointest. Liver Physiol., vol. 286, 2004, pp. G613-G626.
Grozdanov et al., “Analysis of the genome structure of the nonpathogenic probioticEscherichia coliStrain Nissle 1917”, vol. 186, No. 16, Aug. 2004, pp. 5432-5441.
Henker et al., Pediatric Gastroenterology, Hepatology and Nutrition, “Maintenance Therapy of Ulcerative Colitis in Children and Teenagers wit lithe ProbioticE. coliStrain Nissle 1917”, 2. Weltkongress of Jul. 3-7, 2004, pp. 523-527.
Wehkamp et al., “NF-kB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells byEscherichia coliNissle 1917: a novel effect of a probiotic bacterium”, Infection and Immunity, Oct. 2004, vol. 72, No. 10, pp. 5750-5758.
von Buenau et al., “Escherichia coliStrain Nissle 1917: significant reduction of neonatal calf diarrhea”, J. Dairy Sci, vol. 88, 2005, pp. 317-323.
Cross et al, “Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria”, FEMS Immunology and Medical Microbiology, vol. 42, pp. 173-180, 2004.

Affiliated with

Also associated with

Rating

Plasmid-free clone of E. coli strain DSM 6601 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Plasmid-free clone of E. coli strain DSM 6601, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plasmid-free clone of E. coli strain DSM 6601 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2712032